Regatta Capital Group LLC Sells 97 Shares of The Cigna Group (NYSE:CI)

Regatta Capital Group LLC lessened its position in The Cigna Group (NYSE:CI) by 8.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,001 shares of the health services provider’s stock after selling 97 shares during the quarter. Regatta Capital Group LLC’s holdings in The Cigna Group were worth $276,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. ORG Wealth Partners LLC bought a new position in shares of The Cigna Group in the 4th quarter worth about $34,000. Ulland Investment Advisors LLC raised its position in shares of The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Prospera Private Wealth LLC bought a new position in The Cigna Group in the 3rd quarter worth about $37,000. Harbor Capital Advisors Inc. purchased a new stake in The Cigna Group during the 3rd quarter valued at about $45,000. Finally, Intact Investment Management Inc. purchased a new position in The Cigna Group in the third quarter worth about $69,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Trading Down 0.3 %

Shares of CI opened at $294.18 on Friday. The company’s fifty day moving average is $297.18 and its 200 day moving average is $325.61. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The stock has a market capitalization of $81.82 billion, a PE ratio of 27.75, a P/E/G ratio of 0.78 and a beta of 0.54.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating the consensus estimate of $7.22 by $0.29. The firm had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The company’s revenue for the quarter was up 29.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.77 EPS. Sell-side analysts expect that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have issued reports on CI shares. Truist Financial lowered their target price on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Barclays lifted their price objective on The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a report on Monday, November 4th. Royal Bank of Canada dropped their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $395.93.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.